GEDI Act
United States116th CongressHR-3109House of Representatives
Updated: Jun 6, 2019
Summary
Gestational Diabetes Act of 2019 or the GEDI Act This bill amends the Public Health Service Act to direct the Centers for Disease Control and Prevention (CDC) to develop a multisite gestational diabetes (i.e., diabetes occuring during pregnancy) research project to expand and enhance surveillance data and public health research about gestational diabetes. The CDC must: (1) award grants for demonstration projects to reduce the incidence of gestational diabetes, the recurrence of such disease in subsequent pregnancies, and the development of type 2 diabetes in women with a history of gestational diabetes; and (2) work with state and tribal diabetes prevention and control programs assisted by the CDC to encourage postpartum follow-up after gestational diabetes to reduce the incidence of gestational diabetes and its recurrence, the development of type 2 diabetes in at-risk women, and related complications.
Bill texts
All available records shown.
Timeline
Referred to the House Committee on Energy and Commerce.
House of Representatives
Introduced in House
Referred to the Subcommittee on Health.
House of Representatives
All available records shown.